NCT00607841 2019-05-06
A Study of Ispinesib in Metastatic Breast Cancer
Cytokinetics
Phase 1 Terminated
Clinical Trials
7 trialsNCT00089973 2018-02-26
Study Of Ispinesib In Subjects With Breast Cancer
GlaxoSmithKline
Phase 2 Completed
NCT00136578 2017-09-25
Ispinesib In Combination With Carboplatin In Patients With Solid Tumors
GlaxoSmithKline
Phase 1 Completed
NCT00085813 2010-10-04
Ispinesib In Patients With Advanced Or Metastatic Non-Small Cell Lung Cancer
GlaxoSmithKline
Phase 2 Completed
NCT00097409 2010-10-04
Ispinesib In Subjects With Platinum-Taxane-Refractory Or Resistant Relapsed Ovarian Cancer
GlaxoSmithKline
Phase 2 Completed
NCT00119171 2008-10-16
Ispinesib In Combination With Capecitabine In Patients With Solid Tumors
GlaxoSmithKline
Phase 1 Completed
NCT00169520 2008-10-16
SB-715992 In Combination With Docetaxel In Patients With Solid Tumors
GlaxoSmithKline
Phase 1 Completed